Agragene
San Diego, US · Founded 2017 · Delaware corporation · 4 known investors
Agragene develops Precision-Guided Sterile Insect Technology (pgSIT) marketed as KNOCKOUT™, a biocontrol product for controlling crop insect pests such as Spotted Wing Drosophila while reducing reliance on traditional insecticides. It serves agricultural growers of berries and cherries in the US and Canada, working alongside integrated pest management programs.
Founders & leadership
BW
Bryan WitherbeeinPresident and CEO
TE
Tracy EllisNamed on SEC filing
CS
Clyde ShoresNamed on SEC filing
RS
Robert SchmidtNamed on SEC filing
GA
Gordon AltonNamed on SEC filing
DW
David WebbNamed on SEC filing
Board
CC
Investors · 4
Also in the syndicate · 2
BioGeneratorleadOAS
Funding
SEC filings, press & company announcements$2.2M disclosed across 2 of 4 rounds · 2020–2023
- Undisclosed amountA2 financing roundMar 2023
BioGenerator (lead), Ospraie Ag Science
Source ↗
▶$145KraisedFeb 2021 · 1 investors · OtherRule 506(b)
▶$145KraisedFeb 2021 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Tracy EllisExecutive Officer
- Robert SchmidtDirector
- David WebbDirector
- Carl CasaleDirector
- Gordon AltonExecutive Officer, Director
- Clyde ShoresExecutive Officer, Director
- Offering amount
- $145K
- Amount sold
- $145K
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$2.1MraisedAug 2020 · 17 investors · OtherRule 506(b)
▶$2.1MraisedAug 2020 · 17 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Tracy EllisExecutive Officer
- Carl CasaleDirector
- Clyde ShoresExecutive Officer, Director
- Robert SchmidtDirector
- Gordon AltonExecutive Officer, Director
- David WebbDirector
- Offering amount
- $7.5M
- Amount sold
- $2.1M
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlap
Origene17 shared keywordsOriGene develops and supplies genomic and proteomic research tools, including proteins and antibodies built on its proprietary cDNA clone collections, for life science researchers. The company offers a broad catalog of research products used in scientific discovery and diagnostics development.
Neurogene14 shared keywordsNeurogene develops gene therapy treatments for rare neurological diseases. The company aims to make severe genetic neurological conditions treatable for patients and families impacted by these conditions.
Seegene Venture Capital12 shared keywordsSeegene is a molecular diagnostics company; this page is its investor relations section listing quarterly earnings release IR books available for download.
Thumbnail for Seragon Pharmaceuticals8 shared keywordsGenentech is a biotechnology company that develops and manufactures breakthrough medicines in the United States, backed by a $50 billion commitment to U.S. manufacturing and scientific innovation.
Companies competing with Agragene for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Agragene do?
- Agragene develops Precision-Guided Sterile Insect Technology (pgSIT) marketed as KNOCKOUT™, a biocontrol product for controlling crop insect pests such as Spotted Wing Drosophila while reducing reliance on traditional insecticides. It serves agricultural growers of berries and cherries in the US and Canada, working alongside integrated pest management programs.
- Who are Agragene's investors?
- Agragene's investors include Missouri Technology Corporation, Ospraie Ag Science.
- How much funding has Agragene raised?
- Agragene has disclosed $2.2M raised across 2 of its 4 known rounds.
- Where is Agragene headquartered?
- Agragene is headquartered in San Diego, US.